Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer von Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radosław, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

Volltext

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer von Harter, Philipp, Sehouli, Jalid, Vergote, Ignace, Ferron, Gwenael, Reuss, Alexander, Meier, Werner, Greggi, Stefano, Mosgard, Berit J, Selle, Frederic, Guyon, Frédéric, Pomel, Christophe, Lécuru, Fabrice, Zang, Rongyu, Avall-Lundqvist, Elisabeth, Kim, Jae-Weon, Ponce, Jordi, Raspagliesi, Francesco, Kristensen, Gunnar, Classe, Jean-Marc, Hillemanns, Peter, Jensen, Pernille, Hasenburg, Annette, Ghaem-Maghami, Sadaf, Mirza, Mansoor R, Lund, Bente, Reinthaller, Alexander, Santaballa, Ana, Olaitan, Adeola, Hilpert, Felix, du Bois, Andreas

Volltext

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phas... von Ledermann, Jonathan, Prof, Harter, Philipp, MD, Gourley, Charlie, Prof, Friedlander, Michael, Prof, Vergote, Ignace, Prof, Rustin, Gordon, Prof, Scott, Clare L, PhD, Meier, Werner, Prof, Shapira-Frommer, Ronnie, MD, Safra, Tamar, MD, Matei, Daniela, MD, Fielding, Anitra, MBChB, Spencer, Stuart, MSc, Dougherty, Brian, PhD, Orr, Maria, PhD, Hodgson, Darren, PhD, Barrett, J Carl, PhD, Matulonis, Ursula, MD

Volltext

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-cont... von Ledermann, Jonathan A, Prof, Harter, Philipp, MD, Gourley, Charlie, Prof, Friedlander, Michael, Prof, Vergote, Ignace, Prof, Rustin, Gordon, Prof, Scott, Clare, PhD, Meier, Werner, Prof, Shapira-Frommer, Ronnie, MD, Safra, Tamar, MD, Matei, Daniela, MD, Fielding, Anitra, MBChB, Spencer, Stuart, MSc, Rowe, Philip, MSc, Lowe, Elizabeth, MD, Hodgson, Darren, PhD, Sovak, Mika A, MD, Matulonis, Ursula, MD

Volltext

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer von Ledermann, Jonathan, Harter, Philipp, Gourley, Charlie, Friedlander, Michael, Vergote, Ignace, Rustin, Gordon, Scott, Clare, Meier, Werner, Shapira-Frommer, Ronnie, Safra, Tamar, Matei, Daniela, Macpherson, Euan, Watkins, Claire, Carmichael, James, Matulonis, Ursula

Volltext

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial von Shannon, Catherine M, Joly, Florence, Sehouli, Jalid, Canzler, Ulrich, Schmalfeldt, Barbara, Dean, Andrew P, Hein, Alexander, Zeimet, Alain G, Petit, Thierry, Marmé, Frederik, El-Balat, Ahmed, Glasspool, Rosalind, Mahner, Sven, Park-Simon, Tjoung-Won, Mouret-Reynier, Marie-Ange, Costan, Cristina, Reinthaller, Alexander, Goh, Jeffrey C, Kommoss, Stefan, Kurtz, Jean-Emmanuel, Ackermann, Sven, Anthuber, Christoph, Aydogdu, Mustafa, Baldauf, Angelika, Behringer, Dirk, Belau, Antje, Bender, Alexandra, Burges, Alexander, Canzler, Ulrich, Daabach, Trygve, Deryal, Mustafa, El-Balat, Ahmed, Fehm, Tanja, Feisel-Schwickardi, Gabriele, Frank, Matthias, Gebauer, Gerhard, Gerber, Bernd, Gerhardt, Axel, Grafe, Andrea, Griesshammer, Martin, Gropp-Meier, Martina, Hager, Dietrich, Hannig, Carla Verena, Hantschmann, Peer, Harter, Philipp, Hauzenberger, Tanja, Herwig, Uwe, Hilpert, Felix, Jackisch, Christian, Krieger, Peter, Lampe, Björn, Lex, Benno, Lorenz, Ralf, Mahner, Sven, Mallmann, Peter, Marmé, Frederik, Möbus, Volker, Müller, Thomas, Neunhöffer, Tanja, Ober, Angelika, Rautenberg, Beate, Reiter, Wilhelm, Schmalfeldt, Barbara, Scholz, Heinz, Simon, Eike, Sperfeld, Antje, Terhaag, Jürgen, Uleer, Christoph, Vogel, Susanne, Voß, Hermann, Winkler, Ulrich, Wischnik, Arthur, Zorr, Andreas, Glasspool, Ros, Jones, Rachel, Lafleur, Judith, Marth, Christian, Baron-Hay, Sally, Beale, Philip, Begbie, Stephen, Harvey, Sandra, Matos, Marco, Meniawy, Tarek, Olesen, Inger, Shannon, Catherine, Abadie-Lacourtoisie, Sophie, Arsene, Olivier, Barthier, Sophie, Catala, Stéphanie, Dohollou, Nadine, Garnier-Tixidré, Claire, Guardiola, Emmanuel, Hardy-Bessard, Anne-Claire, Joly, Florence, Levache, Charles-Briac, Longo, Raffaele, Lortholary, Alain, Meunier, Jérôme, Raban, Nadia, Vannetzel, Jean-Michel

Volltext

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial von du Bois, Andreas, Prof, Kristensen, Gunnar, Prof, Ray-Coquard, Isabelle, Prof, Reuss, Alexander, MSc, Pignata, Sandro, MD, Colombo, Nicoletta, Prof, Denison, Ursula, MD, Vergote, Ignace, Prof, del Campo, Jose M, MD, Ottevanger, Petronella, PhD, Heubner, Martin, MD, Minarik, Thomas, PhD, Sevin, Emmanuel, MD, de Gregorio, Nikolaus, MD, Bidziński, Mariusz, Prof, Pfisterer, Jacobus, Prof, Malander, Susanne, MD, Hilpert, Felix, Prof, Mirza, Mansoor R, MD, Scambia, Giovanni, Prof, Meier, Werner, Prof, Nicoletto, Maria O, MD, Bjørge, Line, Prof, Lortholary, Alain, MD, Sailer, Martin Oliver, PhD, Merger, Michael, MD, Harter, Philipp, MD

Volltext

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) von Harter, Philipp, Hauke, Jan, Heitz, Florian, Reuss, Alexander, Kommoss, Stefan, Marmé, Frederik, Heimbach, André, Prieske, Katharina, Richters, Lisa, Burges, Alexander, Neidhardt, Guido, de Gregorio, Nikolaus, El-Balat, Ahmed, Hilpert, Felix, Meier, Werner, Kimmig, Rainer, Kast, Karin, Sehouli, Jalid, Baumann, Klaus, Jackisch, Christian, Park-Simon, Tjoung-Won, Hanker, Lars, Kröber, Sandra, Pfisterer, Jacobus, Gevensleben, Heidrun, Schnelzer, Andreas, Dietrich, Dimo, Neunhöffer, Tanja, Krockenberger, Mathias, Brucker, Sara Y, Nürnberg, Peter, Thiele, Holger, Altmüller, Janine, Lamla, Josefin, Elser, Gabriele, du Bois, Andreas, Hahnen, Eric, Schmutzler, Rita

Volltext

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial von Wenham, Robert M, Pickett, Cheryl A, Park, Sang Yoon, Makarova, Yulia, Krikunova, Ludmila, Bae, Duk-Soo, Zamagni, Claudio, Tognon, Germana, Ortega, Eugenia, Green, Andrew, Burger, Robert, Sanchez, Andres Redondo, Peen, Ulla, Kamelle, Scott, Carney, Michael, Forget, Frédéric, Bentley, James, Sehouli, Jalid, Kato, Hidenori, Shahin, Mark, Bhoola, Snehalkumar, Anderson, Daniel, Pelgrims, Joseph (Gino), Hansen, Vincent, Van den Bulck, Heidi, Yokota, Harushige, Friedman, Richard, Covens, Allan, Hilpert, Felix, Savarese, Antonella, Pignata, Sandro, Teneriello, Michael, Lentz, Samuel, Mannel, Robert, Lim, Peter, Zorr, Andreas, Karck, Ulrich, Aoki, Daisuke, Hirashima, Yasuyuki, Boere, Ingrid, Braly, Patricia, Schilder, Jeanne, Secord, Angeles, Rojas-Espaillat, Luis, Schauer, Christian, Joosens, Eric, Burges, Alexander, Park-Simon, Tjoung-Won, Alabiso, Oscar, Sawasaki, Takashi, Ibañez, Ana Herrero, Spillman, Monique, Moore, David, Verhoeven, Didier, Schnappauf, Benjamin, Schmalzrie, Hannah, Kalofonos, Haralambos, Diaz, Cristina Caballero, Polo, Susana Hernando, Garrison, Mitchell, Basil, Jack, Cosin, Jonathan, Wade III, James, Buekers, Thomas, DAndre, Stacy, Bakkum-Gamez, Jamie, Van Le, Linda, Puls, Larry, Michelson, Elizabeth Dickson, Kerger, Joseph, Heubner, Martin, Lordick, Florian, Villanueva, William Orlando Brito, Kessels, Lonneke, Fabregat, Miguel Beltran, Kumar, Pallavi, Karimi, Misagh, Edraki, Babak, Morris, Robert, Method, Michael, Drake, Janet, Wadsworth, Troy, Hurteau, Jean, Malad, Salman, Robinson-Bennett, Bernice, Davidson, Susan, Gaur, Rakesh, Krasner, Carolyn, Ueland, Frederick, Talmage, Lance, Sutton, Gregory, Osborne, Janet, Williams, James, Fleming, Nicole, Herzog, Thomas, Leitao, Mario, Mendez, Luis, Patel, Dhimant, Spitzer, Gary, Miller, Brigitte

Volltext

Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer von Ledermann, Jonathan A, Harter, Philipp, Gourley, Charlie, Friedlander, Michael, Vergote, Ignace, Rustin, Gordon, Scott, Clare, Meier, Werner, Shapira-Frommer, Ronnie, Safra, Tamar, Matei, Daniela, Fielding, Anitra, Bennett, Bryan, Parry, David, Spencer, Stuart, Mann, Helen, Matulonis, Ursula

Volltext

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study von SABBATINI, Paul, HARTER, Philipp, BIDZINSKI, Mariusz, CASADO, Antonio, MARTONI, Andrea, COLOMBO, Nicoletta, HOLLOWAY, Robert W, SELVAGGI, Luigi, LI, Andrew, DEL CAMPO, Jose, CWIERTKA, Karel, PINTER, Tamas, SCAMBIA, Giovanni, VERMORKEN, Jan B, PUJADE-LAURAINE, Eric, SCARTONI, Simona, BERTOLOTTI, Monica, SIMONELLI, Cecilia, CAPRIATI, Angela, MAGGI, Carlo Alberto, BEREK, Jonathan S, PFISTERER, Jacobus, SEHOULI, Jalid, MEIER, Werner, WIMBERGER, Pauline, BAUMANN, Klaus H, KURZEDER, Christian, SCHMALFELDT, Barbara, CIBULA, David

Volltext

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeit... von Wimberger, Pauline, Lehmann, Nils, Kimmig, Rainer, Burges, Alexander, Meier, Werner, Du Bois, Andreas

Volltext

Shedding of Kidney Injury Molecule-1, a Putative Adhesion Protein Involved in Renal Regeneration von Bailly, Veronique, Zhang, Zhiwei, Meier, Werner, Cate, Richard, Sanicola, Michele, Bonventre, Joseph V

Volltext

Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary Cells von Wen, Dingyi, Vecchi, Malgorzata M., Gu, Sheng, Su, Lihe, Dolnikova, Jana, Huang, Yao-Ming, Foley, Susan F., Garber, Ellen, Pederson, Nels, Meier, Werner

Volltext

Teil I: Internationale Perspektive: Strukturwandel

Volltext

Teil II: Nationale Perspektive: Unternehmerische Reaktionen auf Medienwandel und Medienkrise

Volltext

Teil III: Nationale Perspektive: Publizistische, professionelle und individuelle Reaktionen

Volltext

Autorenverzeichnis

Volltext

Teil IV: Umbruch und Aufbruch

Volltext

Zu diesem Buch

Volltext